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Bone Formation and the Wnt Signaling Pathway
To the Editor: Simsek Kiper et al. (June 30 is-
sue)1 link Pyle’s disease to a deficiency of secret-
ed frizzled-related protein 4 (sFRP4), a soluble 
Wnt inhibitor, and demonstrate its specific ef-
fects on cortical bone (which is unusually thin in 
persons with Pyle’s disease) versus trabecular 
bone (which is increased in persons with Pyle’s 
disease). In sFrp4-deficient mice, the inhibition 
of cortical bone formation, which determines 
bone strength at large, was shown to be mediat-
ed through bone morphogenetic protein (BMP)–
dependent induction of sclerostin, a key Wnt inhib-
itor in bone. Given the small amount of trabecular 
bone in the mouse femur, are bone marrow– 
derived osteoblasts that are obtained from the 
femur indeed representative of trabecular bone? 
Second, did the authors assay levels of dickkopf 1 
(Dkk1)? Dkk1 also inhibits Wnt and — like 
sclerostin — is a downstream target of BMP sig-
naling. Therefore, Dkk1, in addition to scleros-
tin, may contribute to the suppression of bone 
formation.2 Moreover, blocking sclerostin increas-
es the expression of Dkk1 in bone, which par-
tially limits the bone-forming effects of scleros-
tin inhibition.3 Thus, Wnt signaling has multiple 
redundant safeguards to fine-tune bone forma-
tion. Therapeutically, this complexity may require 
the use of bispecific antibodies against more than 
one Wnt inhibitor to fully restore Wnt signaling, 
bone formation, and ultimately bone strength.
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The authors reply: We isolated bone marrow–
derived osteoblasts from the femora and tibiae of 
mice that were 10 weeks old, an age at which 
both the femur and the tibia contain trabecular 
bone. It is well established that enhancement of 
canonical Wnt signaling is associated with in-
creases in bone mass.1 Our studies clearly show 
that sFrp4 deficiency has a marked anabolic ef-
fect on trabecular bone in humans and mice. 
Given that trabecular bone resides in the marrow 
and that the properties of sFrp4-deficient bone 
marrow–derived osteoblasts (e.g., the Wnt canoni-
cal pathway — but not the noncanonical pathway 
— is activated in these cells) are consistent with 
the changes observed in trabecular bone (in-
creased bone mass), we concluded that these 
cells better reflect the cellular activities in the 
trabecular bone compartment than do calvarial 
cortical osteoblasts. With regard to the second 
point, sFrp4 deficiency was associated with in-
creased Dkk1 expression in both bone marrow–
derived and calvarial osteoblasts (Fig. 1). This is 
not surprising: Dkk1 is a well-known canonical 
The New England Journal of Medicine 
Downloaded from nejm.org at CTR HOSPITAL UNIVERSITAIRE VAUDOIS on October 27, 2017. For personal use only. No other uses without permission. 
 Copyright © 2016 Massachusetts Medical Society. All rights reserved. 
Correspondence
n engl j med 375;19 nejm.org November 10, 2016 1903
Wnt signaling target gene. We agree with Rauner 
and colleagues: bispecific antibodies against 
sclerostin and Dkk13 could have a stronger effect 
on the maintenance of cortical bone homeostasis 
than do antibodies to only sclerostin.
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Fire-Related Inhalation Injury
To the Editor: In his proposed algorithm for 
the early management of fire-related inhalation 
injury, Sheridan (Aug. 4 issue)1 excluded bron-
choscopy from the recommendations listed as 
standards of care because of the lack of “high-
level proof” of its efficacy. That stance raises 
concern because there are reports that favor the 
use of bronchoscopy in this context. The degree 
of inhalation injury identified on bronchoscopy 
has been reported as a determinant of an inflam-
matory response to smoke inhalation,2 and bron-
choscopic findings have been positively correlat-
ed with mortality.3 Our experience also supports 
the use of bronchoscopy in this situation. In pro-
viding medical care for the victims of a nightclub 
fire in Brazil, we found that serial, flexible bron-
choscopy provided us with information that was 
crucial to the decision-making process with re-
gard to treatment, allowing us to identify the ex-
tent of burns in the airways and to remove large 
amounts of debris (Fig. 1). No complications 
were observed with the use of this procedure. 
Among 18 patients who underwent bronchoscopy 
at our hospital, 16 are still receiving follow-up 
care and have had good clinical outcomes. Thus, 
the limited data available on bronchoscopy can 
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Figure 1. Effect of Sfrp4 Deletion on Dkk1 Messenger 
RNA (mRNA) Expression.
Dkk1 mRNA expression in calvarial osteoblasts and 
bone marrow–derived osteoblasts of wild-type and 
Sfrp4−/− mice after 0, 14, and 28 days of osteogenic 
differentiation is shown. Fold differences in mRNA 
 expression relative to that in wild-type cells were cal-
culated as described by Livak and Schmittgen.2 The 
bars show mean values; T bars indicate standard de-
viations. Three independent experiments were per-
formed at each time point.
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